Search Results - "Munschauer, Frederick E"

Refine Results
  1. 1

    Whole-Brain Atrophy in Multiple Sclerosis Measured by Automated versus Semiautomated MR Imaging Segmentation by Sharma, Jitendra, Sanfilipo, Michael P, Benedict, Ralph H. B, Weinstock-Guttman, Bianca, Munschauer, Frederick E., III, Bakshi, Rohit

    Published in American journal of neuroradiology : AJNR (01-06-2004)
    “…Semiautomated and automated methods are used to measure whole-brain atrophy in multiple sclerosis (MS), but their comparative reliability, sensitivity, and…”
    Get full text
    Journal Article
  2. 2

    Quantitative diffusion weighted imaging measures in patients with multiple sclerosis by Tavazzi, Eleonora, Dwyer, Michael G., Weinstock-Guttman, Bianca, Lema, Jordan, Bastianello, Stefano, Bergamaschi, Roberto, Cosi, Vittorio, Benedict, Ralph H.B., Munschauer, Frederick E., Zivadinov, Robert

    Published in NeuroImage (Orlando, Fla.) (01-07-2007)
    “…Diffusion-weighted imaging (DWI) has been proposed as a sensitive measure of disease severity capable of detecting subtle changes in gray matter and white…”
    Get full text
    Journal Article
  3. 3

    Clopidogrel Responsiveness in Stroke Patients on a Chronic Aspirin Regimen by Sternberg, Zohara, PhD, Ching, Marilou, MD, Sawyer, Robert N., MD, Chichelli, Trevor, MSc, Li, Fan, PhD, Janicke, David, MD, Radovic, Vladan, MD, Mehta, Bijal, MD, Farooq, Osman, MD, Munschauer, Frederick E., MD

    “…This study evaluated the antiplatelet effects of clopidogrel (CPG) in patients sustaining acute ischemic stroke who were already receiving chronic outpatient…”
    Get full text
    Journal Article
  4. 4

    Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis by Herndon, Robert M, Rudick, Richard A, Munschauer, Frederick E, Mass, Michele K, Salazar, Andres M, Coats, Michael E, Labutta, Robert, Richert, John R, Cohan, Stanley L, Genain, Claude, Goodkin, Donald, Toal, Martin, Riester, Katherine

    Published in Multiple sclerosis (01-08-2005)
    “…An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFNβ-1a-Avonex) was conducted to evaluate the immunogenicity and…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Application of hidden Markov random field approach for quantification of perfusion/diffusion mismatch in acute ischemic stroke by Dwyer, Michael G., Bergsland, Niels, Saluste, Erik, Sharma, Jitendra, Jaisani, Zeenat, Durfee, Jacqueline, Abdelrahman, Nadir, Minagar, Alireza, Hoque, Romy, Munschauer, Frederick E., Zivadinov, Robert

    Published in Neurological research (New York) (01-10-2008)
    “…The perfusion/diffusion 'mismatch model' in acute ischemic stroke provides the potential to more accurately understand the consequences of thrombolytic therapy…”
    Get full text
    Journal Article
  8. 8

    Faith-placed cardiovascular health promotion: a framework for contextual and organizational factors underlying program success by Sternberg, Zohara, Munschauer, Frederick E., Carrow, Shannon S., Sternberg, Ernest

    Published in Health education research (01-10-2007)
    “…The objective of this study was to assess the literature on faith-placed cardiovascular health promotion in order to construct a framework of factors meant to…”
    Get full text
    Journal Article
  9. 9

    A community education program on atrial fibrillation: Implications of pulse self-examination on awareness and behavior by Munschauer, Frederick E., Sohocki, Dena, Smith Carrow, Shannon, Priore, Roger L.

    “…Objectives: We postulated that community groups with older demographics could be taught to find and characterize their pulse rhythm for the presence of an…”
    Get full text
    Journal Article
  10. 10

    Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis by Benedict, Ralph H.B., Bruce, Jared, Dwyer, Michael G., Weinstock-Guttman, Bianca, Tjoa, Chris, Tavazzi, Eleonora, Munschauer, Frederick E., Zivadinov, Robert

    Published in Multiple sclerosis (01-07-2007)
    “…Following a previous study with diffusion tensor imaging, we investigated the correlation between diffusion-weighted imaging (DWI) and cognitive dysfunction in…”
    Get full text
    Journal Article
  11. 11

    Assessment and management of neutralizing antibodies in patients with multiple sclerosis by Hartung, Hans-Peter, Munschauer, 3rd, Frederick E

    Published in Journal of neurology (01-06-2004)
    “…The development of neutralizing antibodies (NAbs) to interferon beta (IFNbeta) products during treatment of MS poses a challenge for clinicians. Given the…”
    Get full text
    Journal Article
  12. 12

    The effects of l-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial by Morrow, Sarah A., Kaushik, Tanya, Zarevics, Peter, Erlanger, David, Bear, Mark F., Munschauer, Frederick E., Benedict, Ralph H. B.

    Published in Journal of neurology (01-07-2009)
    “…Defects in processing speed and memory are common in multiple sclerosis (MS) patients. In other populations, amphetamines have been shown to enhance cognition,…”
    Get full text
    Journal Article
  13. 13

    Geographical variation of cerebrovascular disease in New York State: the correlation with income by Han, Daikwon, Carrow, Shannon S, Rogerson, Peter A, Munschauer, Frederick E

    “…Income is known to be associated with cerebrovascular disease; however, little is known about the more detailed relationship between cerebrovascular disease…”
    Get full text
    Journal Article
  14. 14

    MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis by Stosic, Milena, Ambrus, Julian, Garg, Neeta, Weinstock-Guttman, Bianca, Ramanathan, Murali, Kalman, Bernadette, Minagar, Alireza, Munschauer, Frederick E., Galey, Timothy M., Hussein, Sara, Bakshi, Rohit, Zivadinov, Robert

    Published in Journal of neurology (2010)
    “…MRI findings of primary anti-phospholipid antibody syndrome (PAPLS) are difficult to distinguish from those of multiple sclerosis (MS). Only a few previous…”
    Get full text
    Journal Article
  15. 15

    Cortical Atrophy and Personality in Multiple Sclerosis by Benedict, Ralph H. B, Hussein, Sarah, Englert, Jessica, Dwyer, Michael G, Abdelrahman, Nadir, Cox, Jennifer L, Munschauer, Frederick E, Weinstock-Guttman, Bianca, Zivadinov, Robert

    Published in Neuropsychology (01-07-2008)
    “…Although the cognitive disorder of multiple sclerosis (MS) is well characterized, little is known about personality changes that may occur in this disease…”
    Get full text
    Journal Article
  16. 16

    Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients by Garg, Neeta, Zivadinov, Robert, Ramanathan, Murali, Vasiliu, Irene, Locke, Jaclyn, Watts, Kelly, Lema, Jordan, Rajeswary, Jyotsna, Munschauer, Frederick E, Ambrus, Julian, Weinstock-Guttman, Bianca

    Published in Journal of neuroimmunology (01-07-2007)
    “…Abstract Background: Autoreactive antibodies (ARAB) occur more frequently in patients with multiple sclerosis (MS) than in general population and the presence…”
    Get full text
    Journal Article
  17. 17

    Best practice recommendations for the selection and management of patients with multiple sclerosis receiving natalizumab therapy by Coyle, Patricia K, Foley, John F, Fox, Edward J, Jeffery, Douglas R, Munschauer, Frederick E, Tornatore, Carlo

    Published in Multiple sclerosis (01-11-2009)
    “…Natalizumab, a humanized monoclonal antibody directed against α4-integrin is a first-in-class disease-modifying therapy for the treatment of relapsing multiple…”
    Get full text
    Journal Article
  18. 18

    Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity by Bermel, Robert A, Puli, Srinivas R, Rudick, Richard A, Weinstock-Guttman, Bianca, Fisher, Elizabeth, Munschauer, 3rd, Frederick E, Bakshi, Rohit

    Published in Archives of neurology (Chicago) (01-09-2005)
    “…Gray matter magnetic resonance imaging T2 hypointensity, a marker of iron deposition, is associated with clinical impairment and brain atrophy in…”
    Get more information
    Journal Article
  19. 19

    Thalamic Involvement in Multiple Sclerosis: A Diffusion-Weighted Magnetic Resonance Imaging Study by Fabiano, Andrew J., Sharma, Jitendra, Weinstock-Guttman, Bianca, Munschauer III, Frederick E., Benedict, Ralph H. B., Zivadinov, Robert, Bakshi, Rohit

    Published in Journal of neuroimaging (01-10-2003)
    “…ABSTRACT Background and Purpose. Injury to deep gray matter structures in multiple sclerosis (MS) has been suggested by recent neuroimaging and neuropathology…”
    Get full text
    Journal Article
  20. 20

    Lp-PLA2: Inflammatory Biomarker of Vascular Risk in Multiple Sclerosis by Sternberg, Zohara, Drake, Alison, Sternberg, Daniel S., Benedict, Ralph H. B., Li, Fan, Hojnacki, David, Weinstock-Guttmann, Bianca, Munschauer, Frederick E.

    Published in Journal of clinical immunology (01-06-2012)
    “…A member of the A2 phospholipase superfamily, the enzyme lipoprotein-associated phospholipase A2 (Lp-PLA2), is involved in atherogenic processes. Lp-PLA2 mass…”
    Get full text
    Journal Article